BCDIN3D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.026300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.558800E-01
Normal-vs-Stage2
2.692400E-02
Normal-vs-Stage3
6.423500E-02
Normal-vs-Stage4
3.941000E-01
Stage1-vs-Stage2
1.539740E-03
Stage1-vs-Stage3
3.884000E-02
Stage1-vs-Stage4
2.780600E-01
Stage2-vs-Stage3
1.545370E-01
Stage2-vs-Stage4
7.267800E-01
Stage3-vs-Stage4
3.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.978400E-02
Normal-vs-AfricanAmerican
2.536200E-01
Normal-vs-Asian
1.197710E-02
Caucasian-vs-AfricanAmerican
6.212600E-01
Caucasian-vs-Asian
1.701750E-01
AfricanAmerican-vs-Asian
1.000960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.867600E-02
Normal-vs-Female
8.518100E-02
Male-vs-Female
3.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.015000E-01
Normal-vs-Age(41-60Yrs)
5.997900E-02
Normal-vs-Age(61-80Yrs)
5.264400E-02
Normal-vs-Age(81-100Yrs)
9.342300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.330400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.988100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.406300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.440400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.096600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.880800E-03
Normal-vs-Daily Drinker
5.315900E-02
Normal-vs-Weekly Drinker
7.421900E-02
Normal-vs-Occasional Drinker
7.969600E-02
Normal-vs-Social Drinker
1.528160E-01
Non Drinker-vs-Daily Drinker
5.529200E-01
Non Drinker-vs-Weekly Drinker
7.600400E-01
Non Drinker-vs-Occasional Drinker
1.449790E-01
Non Drinker-vs-Social Drinker
8.857300E-03
Daily Drinker-vs-Weekly Drinker
8.640800E-01
Daily Drinker-vs-Occasional Drinker
4.752400E-01
Daily Drinker-vs-Social Drinker
9.262000E-02
Weekly Drinker-vs-Occasional Drinker
4.267000E-01
Weekly Drinker-vs-Social Drinker
9.633600E-02
Occasional Drinker-vs-Social Drinker
2.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.063570E-01
Normal-vs-Grade 2
1.897800E-01
Normal-vs-Grade 3
1.607550E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.480400E-02
Grade 1-vs-Grade 3
5.119900E-02
Grade 1-vs-Grade 4
1.063570E-01
Grade 2-vs-Grade 3
8.420400E-01
Grade 2-vs-Grade 4
1.897800E-01
Grade 3-vs-Grade 4
1.607550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.180400E-02
Normal-vs-NonDiabetic
4.067800E-02
Diabetic-vs-NonDiabetic
3.820800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.636400E-02
Normal-vs-NoPancreatitis
5.030300E-02
Pancreatitis-vs-NoPancreatitis
4.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.778600E-01
Normal-vs-N1
2.363800E-02
N0-vs-N1
1.108560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.636200E-01
Normal-vs-TP53-NonMutant
5.474200E-01
TP53-Mutant-vs-TP53-NonMutant
1.384310E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
